BeCare Link uses AI to better manage MS symptoms
BeCare Link CEO Alan Gilbert says the digital therapeutic company is using artificial intelligence to predict disease progression for multiple sclerosis patients – helping improve care, lower costs and decrease hospitalizations. (Source: Healthcare ITNews Videos)
Source: Healthcare ITNews Videos - May 13, 2019 Category: Information Technology Tags: Artificial Intelligence HIMSS19 Source Type: video
NIH Director's Seminar: From molecular understanding of multiple sclerosis to personalized treatments
NIH Director's Seminar
Polygenic diseases have complex pathophysiology and disease heterogeneity, where diverse mechanisms drive disability progression in different patients. Effective treatments of such diseases require patient-specific therapies that target all mechanisms contributing to the patient ’ s disease expression. Although many putative pathogenic mechanisms have been identified in central nervous system (CNS) autopsy materials from patients with neuroinflammatory diseases such as multiple sclerosis (MS), current clinical practice cannot measure these processes in living human subjects. This limits drug develo...
Source: Videocast - All Events - April 30, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video
Barry Singer, MD - Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin? (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - January 23, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Barry Singer, MD - Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin? (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - January 23, 2019 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Aaron Boster, MD - Potential Clinical Implications of the Latest Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis: A Recap From Paris
Potential Clinical Implications of the Latest Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis: A Recap From Paris (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - February 5, 2018 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Transcriptional Regulation of Neuroinflammation
NCI's Center for Cancer Research (CCR) Grand Rounds
Dr. Lazarevic received her B.Sc. Microbiology degree from the University of Nottingham (UK) and Ph.D. degree in Molecular Virology and Microbiology from the University of Pittsburgh. Following her post-doctoral training in the laboratory of Dr. Laurie Glimcher at Harvard School of Public Health, Dr. Lazarevic was recruited as a tenure-track investigator in the Experimental Immunology Branch, CCR. Her laboratory is interested in how transcription factors regulate differentiation and effector function of CD4+ T helper (Th) cells in the context of autoimmune disorders with e...
Source: Videocast - All Events - November 13, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
Aaron Boster, MD - Harnessing the Full Potential of Disease-Modifying Therapy Mechanisms of Action to Improve Outcomes in Multiple Sclerosis
Harnessing the Full Potential of Disease-Modifying Therapy Mechanisms of Action to Improve Outcomes in Multiple Sclerosis (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - September 1, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Edward J. Fox, MD, PhD - Guiding Patients Through the Risks and Benefits of Disease-Modifying Therapy: Patient Stories of Shared Decision-Making Throughout the Course of Multiple Sclerosis
Guiding Patients Through the Risks and Benefits of Disease-Modifying Therapy: Patient Stories of Shared Decision-Making Throughout the Course of Multiple Sclerosis (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - August 9, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Gavin Giovannoni, MBBCH, PhD, FCP, FRCP, FRCPath - Highly Effective Disease-Modifying Therapies for Multiple Sclerosis: When and In Whom Should They Be Used?
Highly Effective Disease-Modifying Therapies for Multiple Sclerosis: When and In Whom Should They Be Used? (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - July 26, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Barry Singer, MD - Examining the Clinical Implications of Late-Breaking Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis Management: What Are the Key Learnings From Boston?
Examining the Clinical Implications of Late-Breaking Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis Management: What Are the Key Learnings From Boston? (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - July 10, 2017 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Imaging lesion development and repair in multiple sclerosis
NIH Director's Seminar SeriesAir date: 6/16/2017 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - June 8, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
CC Grand Rounds: 1) New Magnetic Resonance Imaging (MRI)-based Diagnostic Approaches to Multiple Sclerosis and 2) New Magnetic Resonance Imaging (MRI)-based Diagnostic Approaches to Multiple Sclerosis
For more information go tohttp://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 5/24/2017 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - April 27, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
Strategies for Neuroprotection and Myelin Repair
NIH Neuroscience Series Seminar
Our ability to move, think, perceive, is dependent on a timely transmission of information among specialized cells called neurons. This information is sent via a series of electrical impulses that travel along specialized structures called " axons " , whose ability to conduct signal is dependent on the presence of " myelin " . Myelin is a fatty substance composed of lipids and proteins that is an integral component of a cell called " oligodendrocyte " . Oligodendrocytes are the myelin-forming cells of the CNS and are essential for brain function. Oligodendrocytes originate from neural stem c...
Source: Videocast - All Events - March 31, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
Edward J. Fox, MD, PhD - Personalizing Multiple Sclerosis Care in an Era of New Therapeutic Options and Updated Clinical Course Descriptions
Personalizing Multiple Sclerosis Care in an Era of New Therapeutic Options and Updated Clinical Course Descriptions (Source: Peerview CME/CE Video Podcast - Neurology International)
Source: Peerview CME/CE Video Podcast - Neurology International - July 20, 2016 Category: Neurology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
